Lexicon Pharmaceuticals | LXRX - PE Price to Earnings


Lexicon Pharmaceuticals reported 12.44 in PE Price to Earnings for its fiscal quarter ending in June of 2021.





Pe Change Date
Abbott 30.71 14.41 Dec/2025
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics 23.16 7.7 Dec/2025
Illumina 30.38 15.53 Dec/2025
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 23.62 0.86 Dec/2025
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
MannKind 303.7 273.14 Dec/2025
Merck 13.92 5.08 Dec/2025
Moderna 27.22 14.51 Jun/2023
Novartis 15.74 0.15 Sep/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics 27.27 0 Sep/2025
Thermo Fisher Scientific 31 6.22 Dec/2025
United Therapeutics 17.32 1.62 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023